Norwegian (OSEAX) Groei aandelen Pharmaceuticals & Biotech

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Jun 13, 2026

Ontdek Norwegian Pharmaceuticals & Biotech Groeiaandelen die op de OSEAX. Gesorteerd op voorspelde groei, hebben deze Pharmaceuticals & Biotech Stocks een hoger dan verwachte winst- of omzetgroei in vergelijking met andere bedrijven.

Bedrijf	Laatste prijs	7D Terugkeer	1 J Rendement	Marktkapitalisatie	Doel analisten	Waardering	Groei	Div Opbrengst
NAVA	NOK 16.75	-0.3%	-22.1%	NOK 401.7m	NOK 26.00	1.3	105.5%	n/a
AZT	NOK 20.90	0.5%	24.8%	NOK 1.1b	NOK 31.00	79.5	46.0%	n/a
NYKD	NOK 3.15	-3.1%	71.2%	NOK 1.0b	NOK 5.00	194.6	27.0%	28.9%
TRMED	NOK 4.19	1.2%	58.5%	NOK 1.5b	NOK 3.50	1802.6	26.0%	n/a
ONCIN	NOK 43.80	0.2%	n/a	NOK 196.2m	NOK 59.50	7.0	21.4%	n/a
PHO	NOK 59.70	1.4%	16.8%	NOK 1.6b	NOK 85.00	18.8	-22.0%	n/a
LYTIX	NOK 8.90	-10.3%	-6.1%	NOK 684.4m	NOK 15.00	11.1	-25.2%	n/a
EXTX	NOK 0.84	11.9%	-71.5%	NOK 53.5m	n/a	906.1	n/a	n/a
CRNA	NOK 8.16	-3.1%	1,209.8%	NOK 1.9b	n/a	-42.3	n/a	n/a
VISTN	NOK 20.50	0.5%	-15.6%	NOK 909.1m	n/a	12.2	n/a	7.3%
NORD	NOK 86.40	0%	n/a	NOK 443.4m	n/a	3.5	n/a	30.1%
ZLNA	NOK 20.50	-10.5%	44.9%	NOK 538.5m	n/a	67316.4	n/a	n/a
HBC	NOK 1.18	-11.0%	-42.7%	NOK 483.0m	n/a	1.9	n/a	n/a
ABS	NOK 3.43	0%	-9.0%	NOK 92.5m	n/a	2.2	n/a	n/a
SOFTX	NOK 0.11	-10.7%	38.2%	NOK 284.7m	n/a	18.3	n/a	n/a

Page 1 of 1